| Literature DB >> 32422192 |
Tim T Wang1, Hwi Sean Moon2, Anh Le3, Neeraj Panchal4.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has affected the world in unprecedented ways. It is clear that this pandemic, unlike any public health challenge in recent memory, has the potential to fundamentally alter the delivery of many healthcare services, including the practice of oral and maxillofacial surgery. In response to this global health crisis, the Oral and Maxillofacial Surgery (OMS) COVID-19 Response Conference was held virtually on April 9, 2020, organized by oral and maxillofacial surgeons (OMSs) and administrators from multiple institutions to provide a forum for OMSs to discuss how COVID-19 has affected the specialty. As evidence-based information on COVID-19 continues to emerge, the present report serves as a method to disseminate the current opinions and management strategies from a variety of experts in OMS. Published by Elsevier Inc.Entities:
Mesh:
Year: 2020 PMID: 32422192 PMCID: PMC7211734 DOI: 10.1016/j.joms.2020.05.003
Source DB: PubMed Journal: J Oral Maxillofac Surg ISSN: 0278-2391 Impact factor: 1.895
Figure 1Calculation of coronavirus disease 2019 (COVID-19) exposure from an asymptomatic patient with negative COVID-19 test result according to particle filtration efficiency (PFE) of the mask. ∗Risk can be calculated by a PFE of 0.1 μm of the mask worn. If the mask protects against 95% of particles at a PFE of 0.1 μm, the risk of viral particle exposure is 5%.